The Australasian Professional Society on Alcohol and other Drugs' submission to the consultation draft National Tobacco Strategy 2022-2030.

Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 9015440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1465-3362 (Electronic) Linking ISSN: 09595236 NLM ISO Abbreviation: Drug Alcohol Rev Subsets: MEDLINE

Publication: Original Publication: Abingdon, Oxfordshire, U.K. : Carfax Pub. Co.,

Smoking Cessation* ; Societies* ; Tobacco Use*/adverse effects ; Tobacco Use*/epidemiology ; Tobacco Use*/prevention & control; Humans ; Australasia ; Australia/epidemiology ; Electronic Nicotine Delivery Systems ; Policy

Tobacco use continues to be a leading cause of death and morbidity globally. At the core of Australia's response to tobacco-related harms is the National Tobacco Strategy which highlights a national collaborative framework to reduce prevalence, and associated health, social and economic impacts of tobacco use. A draft National Tobacco Strategy (2022-2030) has recently been released for consultation and as members of the Australasian Professional Society on Alcohol and other Drugs' Special Interest Group for Smoking Cessation Professionals we provide a commentary on key successes of the previous National Tobacco Strategy, and suggestions for improvement areas to strengthen Australia's policy response to tobacco and e-cigarette-related issues.
(© 2023 The Authors. Drug and Alcohol Review published by John Wiley & Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs.)

World Health Organization. Framework convention on tobacco control. Geneva, Switzerland: WHO Document Production Services; 2005.
Commonwealth of Australia. National Tobacco Strategy 2012-2018 - a strategy to improve the health of all Australians by reducing the prevalence of smoking and its associated health, social and economic costs, and the inequalities it causes. Canberra: Commonwealth of Australia; 2012.
Australian Government Department of Health and Aged Care. National Drug Strategy Canberra: Australian Government Department of Health and Aged Care; 2021 (updated 13 September 2021). Available from: https://www.health.gov.au/resources/collections/national-drug-strategy.
Australian Government Department of Health and Aged Care. National Tobacco Strategy Canberra: Australian Government Dept. of Health and Aged Care; 2022 (updated 10 February 2022; cited 2022 15 August). Available from: https://www.health.gov.au/initiatives-and-programs/national-tobacco-strategy#:~:text=The%20National%20Tobacco%20Strategy%20is,Australians%20by%20reducing%20tobacco%20use.
Australian Government Department of Health and Aged Care. Consultation Draft National Tobacco Strategy 2022-2030 [PDF]. Canberra: Australian Government Dept. of Health and Aged Care; 2022 (cited 15 August 2022). Available from: https://consultations.health.gov.au/atodb/national-tobacco-strategy-2022-2030/.
Australian Government Dept of Health and Aged Care. Nicotine and Smoking Cessation Counselling MBS Services: MBS Online; 2021 (updated 23 July 2021). Available from: http://www9.health.gov.au/mbs/fullDisplay.cfm?type=item&qt=ItemID&q=93692#:~:text=93692%20%2D%20Additional%20Information&text=(e)%20providing%20the%20patient%20with,with%20appropriate%20documentation.
NICE. Tobacco: preventing uptake, promoting quitting and treating dependence. UK: National Institute for Health and Care Excellence; 2022 (cited 15 August 2022). Available from: www.nice.org.uk/guidance/ng209.
Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11:CD000146.
Bittoun R. A combination nicotine replacement therapy (NRT) algorithm for hard-to-treat smokers. J Smok Cessat. 2006;1:3-6.
Courtney RJ, Boland VC, McRobbie H. Inequalities in cessation and critique of possible contributing factors: taking stock of a perseveration with current treatment approaches, uptake of promising treatments and limited upscaling of interventions with positive equity impact. Addiction. 2020;115:1788-90.
Mersha AG, Eftekhari P, Bovill M, Tollosa DN, Gould GS. Evaluating level of adherence to nicotine replacement therapy and its impact on smoking cessation: a systematic review and meta-analysis. Arch Public Health. 2021;79:26.
Pharmaceutical Benefits Advisory Committee. Pharmaceutical Benefits Advisory Committee Meeting Outcomes May 2022 PBAC Intracycle Meeting 2022. Available from: https://www.pbs.gov.au/industry/listing/elements/pbac-meetings/pbac-outcomes/2022-05/May-2022-PBAC-Web-Outcomes.pdf.
Tutka P, Vinnikov D, Courtney RJ, Benowitz NL. Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation. Addiction. 2019;114:1951-69.
Courtney RJ, McRobbie H, Tutka P, Weaver NA, Petrie D, Mendelsohn CP, et al. Effect of Cytisine vs Varenicline on smoking cessation. JAMA. 2021;326:56-64.
Walker N, Smith B, Barnes J, Verbiest M, Parag V, Pokhrel S, et al. Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial. Addiction. 2021;116:2847-58.
Zwar N, Richmond R, Borland R, Peters M, Mendelsohn C, Litt J, et al. Supporting smoking cessation: a guide for health professionals. Second ed. Melbourne: The Royal Australian College of General Practitioners; 2019.
Therapeutic Goods Administration. Nicotine vaping product access. 2022.
Banks E, Beckwith K, Joshy G. Summary report on use of e-cigarettes and relation to tobacco smoking uptake and cessation, relevant to the Australian context. Canberra, ACT: The Australian National University; 2021.
Banks E. Evidence on efficacy of e-cigarettes for supporting smoking cessation and evidence on adverse effects. Nicotine and Smoking Cessation Update Day: Australasian Smoking Cessation Professionals Special Interest Group- APSAD; 2021.
Hartmann-Boyce J, McRobbie H, Butler AR, Lindson N, Bullen C, Begh R, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2021.
Brownell KD, Warner KE. The perils of ignoring history: big tobacco played dirty and millions died. How similar is big food? Milbank Q. 2009;87:259-94.
Australian Government Department of Health and Aged Care. Mid-point review of the National Tobacco Strategy 2012-2018 2016 (updated 18 May 2017). Available from: https://www.health.gov.au/resources/publications/mid-point-review-of-the-national-tobacco-strategy-2012-2018.
Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y, Dobson R. Mobile phone text messaging and app-based interventions for smoking cessation. Cochrane Database Syst Rev. 2019;10:CD006611.
World Health Organization. Mobile Health for Tobacco Cessation (mTobaccoCessation). Be He@lthy Be Mobile Handbook. Available from: https://www.who.int/publications/i/item/978924154981-3.
Clare P, Slade T, Courtney RJ, Martire KA, Mattick RP. Use of smoking cessation and quit support services by socioeconomic status over 10 years of the National Drug Strategy Household Survey. Nicotine Tob Res. 2014;16:1647-55.
Barry M, Saul J, Bailey L. U.S. Quitlines at a crossroads: utilization, budget, and service trends 2005-2010. North American Quitline Consortium 2010.
Australian Institute of Health and Welfare. National Drug Strategy Household Survey 2019, Summary. Canberra, ACT: Australian Institute of Health and Welfare; 2020.
Boland VC, Mattick RP, McRobbie H, Siahpush M, Courtney RJ. “I'm not strong enough; I'm not good enough. I can't do this, I'm failing”: a qualitative study of low-socioeconomic status smokers' experiences with accessing cessation support and the role for alternative technology-based support. Int J Equity Health. 2017;16:196.
Boland VC, Stockings EA, Mattick RP, McRobbie H, Brown J, Courtney RJ. The methodological quality and effectiveness of technology-based smoking cessation interventions for disadvantaged groups: a systematic review and meta-analysis. Nicotine Tob Res. 2017;20:276-85.
Borland R, Segan C, Livingstone P, Owen N. The effectiveness of call back counselling for smoking cessation: a randomised trial. Addiction. 2001;96:881-9.
Tzelepis F, Paul CL, Wiggers J, Walsh RA, Knight J, Duncan SL, et al. A randomised controlled trial of proactive telephone counselling on cold-called smokers' cessation rates. Tob Control. 2010;20:40-6.
National Best Practice U. NBPU TIS update 27 June. Tackling indigenous smoking (TIS). Newsletter. 2022;7(6): Available from: https://tacklingsmoking.org.au/newsletters/.

Keywords: e-cigarettes; nicotine replacement therapy; policy; smoking cessation; tobacco smoking

Date Created: 20230126 Date Completed: 20230622 Latest Revision: 20230622

20231215

10.1111/dar.13603

36698287